CION Ameerpet
Immunotherapy · When It Stops Working & Difficult Decisions
When the Money Runs Out — Before the Treatment Does
Running out of money is one of the most common reasons cancer treatment ends early in India, and one of the least written about. If you cannot afford to continue, you still have choices — and stopping one treatment is not the same as stopping care. This page sets out the real options, honestly, with no pressure in either direction.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- It is not just continue or stop — Switching to a lower-cost regimen, spacing doses, agreeing a stopping point or pausing with a review date are all real options to raise.
- Partial treatment is not wasted — Stopping part-way is not the same as never having started, and what you have already had still shapes what your team offers next.
- Support exists and is under-used — State schemes, government relief funds, manufacturer programmes and hospital social workers help more families than most people realise.
- Palliative care runs alongside — Symptom and quality-of-life care is a parallel service available from diagnosis onward, not a last resort once the money is gone.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The short answer
What Are My Options If I Cannot Afford to Continue Cancer Treatment?
You have more than two. Between continuing as planned and stopping altogether sit four other options: switch to a lower-cost regimen, space the doses or agree a defined stopping point, pause with a fixed review date, or move to supportive care only. Ask your oncologist to price and rule on each one.
This is one of the most common reasons cancer treatment ends early in India, and one of the least written about. WHO and ICMR have both flagged out-of-pocket cancer costs as a major driver of treatment being abandoned. Your oncology team sees it every week.
Did you know?
Cost — not side effects, and not the treatment failing — is one of the most common reasons cancer treatment stops early in India. WHO and ICMR have both identified out-of-pocket cancer spending as a major cause of treatment being abandoned. Raising it with your oncologist is a clinical conversation, and it often changes the plan while changing it still helps.
A framework, not a recommendation
What Does Each Option Actually Involve?
Which options are genuinely open depends on your cancer type, stage and how you are doing. This is a starting point for the conversation with your oncologist, not a ranking — and choosing not to continue is a legitimate option on it, not a failure.
| Option | What it involves | Worth raising if |
|---|---|---|
| Continue the current plan | Finishing the cycles already planned, with the funding you have arranged | A scheme or policy still holds, or the remaining course is short |
| Switch to a lower-cost option | A biosimilar version, or a different approved regimen for your cancer type, where one exists | Cost per cycle is the blocker, not the treatment itself |
| Change the schedule or duration | Longer intervals between doses, or an agreed stopping point instead of an open-ended course | You tolerate treatment well and the plan has no defined end date |
| Pause with a fixed review date | Stopping for now while scans, blood tests and reviews continue on a set schedule | Funds are temporarily blocked — a claim, approval or loan is pending |
| Supportive and palliative care only | Symptom control, pain management and quality-of-life care, without disease-directed treatment | The cost and burden of continuing outweigh what it is expected to achieve |
| Ask about a clinical trial | Some trials supply the study treatment and related tests at no cost to the participant | You are well enough and a trial for your cancer type is open near you |
A trial is not a funding scheme. Eligibility is set by the protocol and enrolment can never be promised — but asking whether one is open costs nothing.
The question families ask second
Is Partial Immunotherapy Wasted If I Have to Stop Halfway?
No. Stopping part-way is not the same as never having started. Immunotherapy acts through the immune system rather than on the tumour directly, so its effect does not switch off the moment a dose is missed. In a proportion of patients, some effect continues for a period after treatment ends.
How long that lasts in one person cannot be predicted. For some patients the disease does progress after stopping, sometimes soon, and any source offering a number for your own case is overstating what is knowable. What is certain is that the completed cycles showed your team how your scans changed and how well you tolerated treatment — and that shapes what is offered next.
A planned stop is also a recognised idea, not an improvisation. Guideline bodies including NCCN and ESMO describe defined treatment durations for several immunotherapy indications rather than treating indefinitely. Ask your oncologist whether your regimen has a defined end point at all — for some patients, that answer changes the cost conversation entirely.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Do Not Stop Treatment Without Talking to Someone First
A second opinion is free and confidential. It can confirm whether a shorter, cheaper or paused plan is reasonable for your case — or that stopping is.
What support exists
What Financial Support Actually Exists for Cancer Treatment?
More than most families use. Health schemes, insurance, government relief funds, manufacturer assistance programmes and hospital social workers all exist for this situation. Most need paperwork and time, so start them before the money has run out.
1. State and national health schemes
Aarogyasri in Telangana and Andhra Pradesh, and Ayushman Bharat PM-JAY nationally, cover defined cancer packages at empanelled hospitals. Lists and ceilings change, so ask the scheme desk what is covered now.
2. CGHS, ESI, employer and private insurance
CGHS, ESI and employer group policies frequently cover day-care cancer treatment. Ask about infusion cover, pre-authorisation and cashless settlement. Claims fail on paperwork far more often than on the treatment itself.
3. Government relief funds
The Health Minister’s Cancer Patient Fund, the Prime Minister’s National Relief Fund and state Chief Minister’s Relief Funds make grants toward cancer treatment. Applications route through the treating hospital, so start early, not at crisis point.
4. Manufacturer programmes and lower-priced equivalents
Several manufacturers run patient-assistance programmes, and lower-priced biosimilar versions of some immunotherapy molecules are now marketed in India. Your oncologist and hospital pharmacy can say what applies to your prescription.
5. Hospital social workers, NGOs and crowdfunding
Most cancer centres have a medical social worker whose job is precisely this. Cancer NGOs and regulated crowdfunding platforms help many Indian families, though crowdfunding works better started early.
Any cost or scheme ceiling quoted to you is indicative, as of August 2026. Get your own figures in writing from the hospital handling your treatment.
The conversation itself
How Do I Tell My Oncologist We Cannot Afford to Continue?
1
Say it plainly, and say it early
“We cannot sustain this cost” is a clinical fact your team needs, not a confession. Say it at the next review, before cycles get missed.
2
Ask for the remaining plan, priced in full
How many cycles are left, what each costs including scans and blood tests, and what your scheme pays. Indicative figures still beat guessing.
3
Start the paperwork the same week
Scheme approvals and relief-fund applications take time. Ask for a referral to the scheme desk or medical social worker alongside the medical conversation, not after it.
4
Agree what happens either way
Leave with a written plan: which scans, how often, which symptoms mean calling immediately, and who to call. Pausing treatment must never mean losing contact with care.
A parallel service, not a last resort
Is Palliative Care What Happens When the Money Runs Out?
No. WHO defines palliative care as care that improves quality of life for patients and families facing a life-threatening illness, running alongside cancer treatment from diagnosis onward. It is a parallel service, not the thing that starts once treatment stops. Many patients use both at the same time.
It covers pain, breathlessness, nausea, appetite and sleep, plus the load carried by the family. You can ask for a referral while still on immunotherapy, and doing so does not signal that you are giving up. It is usually less expensive and often deliverable closer to home, though the reason to use it is symptom control, not price.
This is where a goals-of-care conversation helps. Rather than asking only whether you can afford the next cycle, it asks what matters most to the patient now — time at home, work, avoiding admissions, controlling pain — and which plan serves that. Cost belongs in it openly.
You do not have to work this out alone
Whatever You Decide, Decide With the Real Numbers
A medical oncologist can price the remaining course, check what your scheme or policy actually pays, and set out the options — including stopping — without pressure either way.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Cannot Afford to Continue Treatment? Your Questions Answered
What are my options if I cannot afford to continue cancer treatment?
You have more than two. Between continuing as planned and stopping altogether sit four others: switch to a lower-cost regimen or biosimilar where one exists, space the doses or agree a defined stopping point, pause with a fixed review date, or move to supportive care only. A trial that supplies the study treatment is worth asking about too. Ask your oncologist to rule each option in or out.
Is partial immunotherapy wasted if I stop halfway?
No. Stopping part-way is not the same as never having started. Immunotherapy acts through the immune system rather than on the tumour directly, so its effect does not stop the moment a dose is missed. In a proportion of patients some effect persists after treatment ends. How long cannot be predicted, and for some the disease progresses soon after. The cycles you completed still showed your team how you responded.
What financial support exists for cancer treatment in India?
More than most families use. Aarogyasri in Telangana and Andhra Pradesh, and Ayushman Bharat PM-JAY nationally, cover defined cancer packages at empanelled hospitals. CGHS, ESI and employer policies often cover day-care treatment. The Health Minister's Cancer Patient Fund, the Prime Minister's National Relief Fund and state Relief Funds make grants through the treating hospital. Manufacturer assistance programmes, lower-priced biosimilars and the hospital medical social worker are also worth asking about, and most need paperwork started early.
Will my oncologist judge me for saying we cannot afford it?
No, and they will almost certainly have had the same conversation that week. WHO and ICMR have both flagged out-of-pocket cancer costs as a major driver of treatment being abandoned in India. Saying it plainly lets your team price the remaining course, check what your scheme pays, and consider a shorter or cheaper plan while changing it still helps. Raise it at the next review, not after cycles have been missed.
Is palliative care the same as giving up on treatment?
No. WHO defines palliative care as care that improves quality of life for patients and families facing a life-threatening illness, running alongside cancer treatment from diagnosis onward rather than starting after it ends. Many patients receive both at once, for pain, breathlessness, nausea, appetite and sleep. You can ask for a referral while still on treatment, and choosing supportive care only is a considered decision.
If we pause immunotherapy for money reasons, can we restart later?
Sometimes, but not always, so ask your oncologist about your own situation rather than assuming. It depends on what your scans show at the time, how well you are overall, and whether the treatment still fits guidelines for your cancer type and stage. A pause is far safer planned than drifting: agree a fixed review date, keep the scans already planned, and know which symptoms mean calling immediately.
This page is general patient-education information, not a substitute for the written guidance your own oncology team gives you based on your diagnosis, treatment plan and scheme eligibility. Any cost or scheme detail mentioned here is indicative, as of August 2026, and must be confirmed by the hospital handling your treatment.